Market cap of Pfizer Inc [PFE] reaches 137.53B – now what?

BFRI Stock

Pfizer Inc [NYSE: PFE] price plunged by -0.21 percent to reach at $47329975.76.

A sum of 39338988 shares traded at recent session while its average daily volume was at 47.33M shares. Pfizer Inc shares reached a high of $24.42 and dropped to a low of $24.08 until finishing in the latest session at $47330000.0.

The one-year PFE stock forecast points to a potential downside of -168374144.04. The average equity rating for PFE stock is currently 2.44, trading closer to a bullish pattern in the stock market.

Guru’s Opinion on Pfizer Inc [PFE]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for PFE shares is $28.11 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on PFE stock is a recommendation set at 2.44. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Cantor Fitzgerald have made an estimate for Pfizer Inc shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on April 22, 2025. While these analysts kept the previous recommendation, BofA Securities raised their target price to Neutral. The new note on the price target was released on December 10, 2024, representing the official price target for Pfizer Inc stock. Previously, the target price had yet another raise to $25, while Wolfe Research analysts kept a Underperform rating on PFE stock.

The Price to Book ratio for the last quarter was 1.52, with the Price to Cash per share for the same quarter was set at 3.05. Price to Free Cash Flow for PFE in the course of the last twelve months was 12.26 with Quick ratio for the last quarter at 0.96.

PFE Stock Performance Analysis:

Pfizer Inc [PFE] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 0.92. With this latest performance, PFE shares gained by 4.36% in over the last four-week period, additionally sinking by -9.43% over the last 6 months – not to mention a drop of -8.82% in the past year of trading.

Insight into Pfizer Inc Fundamentals:

Operating Margin for any stock indicates how profitable investing would be, and Pfizer Inc [PFE] shares currently have an operating margin of 27.53% and a Gross Margin at 66.93%. Pfizer Inc’s Net Margin is presently recorded at 12.59%.

Return on Equity for this stock inclined to 3.67%, with Return on Assets sitting at 3.67%.

PFE Stock EPS

The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for PFE. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Pfizer Inc go to -0.25%.

Pfizer Inc [PFE] Institutonal Ownership Details

There are presently around $67.59%, or 67.63% of PFE stock, in the hands of institutional investors. The top three institutional holders of PFE stocks are: VANGUARD GROUP INC with ownership of 511.4 million shares, which is approximately 9.0258%. BLACKROCK INC., holding 424.38 million shares of the stock with an approximate value of $$11.87 billion in PFE stocks shares; and BLACKROCK INC., currently with $$8.03 billion in PFE stock with ownership which is approximately 5.0663%.

The DBT News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.